Cubed Biotech develops and manufactures psychedelic medicines by cultivating and extracting natural entheogens, such as psilocybin and mescaline, using cGMP mycological methods. The company aims to provide effective alternatives for treating mental illness and addiction through its reverse-engineered drug products, including a clinical trial for a multi-API Ayahuasca pill.
Funding
Funding not disclosed
Founders
Product
Problem
The development of psychedelic medicines often relies on synthetic production methods or inconsistent natural sources, leading to challenges in achieving pharmaceutical-grade consistency and purity. Existing extraction techniques may also lack the scalability and regulatory compliance required for widespread clinical use and patient access.
Solution
Cubed Biotech cultivates and extracts natural entheogens, such as psilocybin and mescaline, using Current Good Manufacturing Practice (cGMP) compliant mycological methods. This approach allows for the production of consistent, high-quality psychedelic compounds suitable for pharmaceutical applications. The company focuses on developing reverse-engineered drug products, including a multi-API Ayahuasca pill, to provide effective alternatives for treating mental illness and addiction. By combining scientific rigor with natural sources, Cubed Biotech aims to bridge the gap between traditional entheogens and modern medicine.
Target Audience
The primary target audience includes pharmaceutical companies, clinical researchers, and healthcare providers seeking reliable sources of natural psychedelic compounds for therapeutic applications in mental health and addiction treatment.
Features
- cGMP-compliant mycological cultivation methods for consistent production of psilocybin and psilocin
- Extraction, purification, and synthesis capabilities to ensure pharmaceutical-grade quality
- Development of a stacked multiple-API formula "Ayahuasca pill" (CB-003) for clinical trials
- Research and development focused on natural psychedelic medicine
- Utilization of unique psilocybe strains of mushrooms